Previous Article | Next Article 
Journal of Bacteriology, January 2009, p. 571-575, Vol. 191, No. 2
0021-9193/09/$08.00+0 doi:10.1128/JB.00950-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Hydrogen Peroxide-Mediated Interference Competition by Streptococcus pneumoniae Has No Significant Effect on Staphylococcus aureus Nasal Colonization of Neonatal Rats
Elisa Margolis*
Department of Biology, Emory University, Atlanta, Georgia 30322
Received 10 July 2008/
Accepted 31 October 2008

ABSTRACT
It has been proposed that the relative scarcity of
Staphylococcus aureus and
Streptococcus pneumoniae cocolonization in the nasopharynxes
of humans can be attributed to hydrogen peroxide-mediated interference
competition. Previously it has been shown in vitro that H
2O
2 produced by
S. pneumoniae is bactericidal to
S. aureus. To ascertain
whether H
2O
2 has this inhibitory effect in the nasal passages
of neonatal rats, colonization experiments were performed with
S. aureus and
S. pneumoniae. The results of these experiments
with neonatal rats are inconsistent with the hypothesis that
hydrogen peroxide-mediated killing of
S. aureus by
S. pneumoniae is responsible for the relative scarcity of cocolonization by
these bacteria. In mixed-inoculum colonization experiments and
experiments where
S. aureus invaded the nasopharynxes of rats
with established
S. pneumoniae populations, the density of
S. aureus did not differ whether the
S. pneumoniae strain was H
2O
2 secreting or non-H
2O
2 secreting (SpxB). Moreover, the advantage
of catalase production by
S. aureus in competition with a non-catalase-producing
strain (KatA) during nasal colonization was no greater in the
presence of H
2O
2-producing
S. pneumoniae than in the presence
of non-H
2O
2-producing
S. pneumoniae.

INTRODUCTION
Recent epidemiological investigations of the carriage of
Staphylococcus aureus and
Streptococcus pneumoniae suggest that cocolonization
by these two commensal (and occasionally invasive) bacteria
is negatively correlated (
1,
7,
11,
16,
24). One corollary of
this observation is that a reduction in the frequency of colonization
by one of these species would lead to a corresponding increase
in the frequency of colonization by the other. In fact, it has
been proposed that the reduction of
S. pneumoniae colonization
due to the pneumococcal conjugate vaccine has played a role
in the increase in
S. aureus acute otitis media and bacteremia
(
5,
23). The mechanism proposed to account for this cocolonization
pattern is interference competition, or allelopathy, mediated
by the killing of
S. aureus by
S. pneumoniae-produced hydrogen
peroxide (H
2O
2) (
19). In broth, high densities of
S. pneumoniae mixed with
S. aureus result in the demise of
S. aureus, and
killing does not occur if the pneumococci genetically lack pyruvate
oxidase (SpxB) or if catalase is present to neutralize the H
2O
2 (
19). While much attention has been given to the appealing hypothesis
that loss of H
2O
2-mediated interference competition by
S. pneumoniae is responsible for the increase in invasive
S. aureus infections,
there has been only indirect confirmation (
14) that this allelopathic
mechanism operates during nasal colonization.
In this study, I tested the effect of H2O2 production by S. pneumoniae on nasal colonization of S. aureus in two scenarios where interspecies interference may occur in a neonatal rat model: the invasion of an established population of S. pneumoniae by S. aureus and the use of mixed inocula of both species. By using isogenic strains of S. pneumoniae that either produce or do not produce H2O2 (SpxB), I demonstrated that H2O2 production by S. pneumoniae has no effect on S. aureus colonization. Furthermore, the advantage of catalase-producing S. aureus in the presence of S. pneumoniae is manifest whether S. pneumoniae produces or does not produce H2O2. I discuss some potential reasons why S. pneumoniae-mediated H2O2 allelopathy is effective against S. aureus in vitro but not in vivo.

MATERIALS AND METHODS
Bacterial strains, media, and inoculum preparation.
S. pneumoniae TIGR4 (
21) and an SpxB-negative variant of TIGR4
(designated SxpB) (
19) were provided by Marc Lipsitch.
S. aureus PS80 (serotype 8, ATTC 27700) and Newman (NCTC 8178) were obtained
from the American Type Culture Collection. A catalase-deficient,
KatA-negative variant of Newman (designated KatA) (
14) was provided
by George Liu.
S. aureus strains were cultivated in Luria-Bertani
(LB) broth cultures and agar plates incubated at 37°C.
S. pneumoniae strains were grown in Todd-Hewitt broth supplemented
with 5 g of yeast extract (THY), and plates were supplemented
with 40 ml of sheep blood (BBL). Broth cultures and agar plates
of
S. pneumoniae were incubated at 37°C with 5% CO
2.
Inocula for all the infant rat experiments were prepared by initially growing strains to late logarithmic phase (optical density of 0.35 to 0.8). These were stored at –80°C and then thawed on the day of the experiment before being suspended in 2 ml of either LB or THY. Cultures that reached mid-exponential phase were centrifuged (5,000 x g, 3 min) and resuspended in phosphate-buffered saline with 0.1% gelatin (PBSG). Inocula and animal specimen densities were estimated by plating dilutions on LB agar plates for Newman or PS80, on LB plates supplemented with spectinomycin (100 mg/liter) for KatA, and on THY blood plates supplemented with streptomycin (40 mg/liter) for TIGR4 or kanamycin (75 mg/liter) for SpxB.
Infant rat model.
All in vivo experiments were preformed under the guidelines approved by the Emory University Institutional Animal Care and Use Committee. Three-day-old pups, born of timed-pregnant Sprague-Dawley rats (Charles River Laboratories), were pooled, randomly reassigned to dams, and maintained in microisolator cages in a biocontainment facility. At 3 or 5 days of age, rats were intranasally inoculated by touching a drop of 106 to 107 bacteria of either a mixture of S. aureus and S. pneumoniae strains or one strain alone suspended in 5 µl PBSG to the right and nares then another such drop to the left external nares (9, 12, 13).
Two days after the inoculation, nasal wash was collected from 200 µl of PBSG instilled into a 5-cm intramedic polyetylene tubing (PE50; Clay Adams) placed into the trachea, and nasal epithelium was scraped from the nasal passages after a second wash with 200 µl of PBSG and removal of the frontal bones. The nasal epithelium, which has been suggested to represent a distinct population (2), was homogenized in 1 ml of PBSG.
In all experiments, 100 µl of the nasal wash and nasal epithelium samples were plated directly and serially diluted onto selective plates. Plates were incubated overnight at 37°C, and all colonies were counted. The limit for detection at any site was 20 CFU/ml.
Experimental design.
In the mixed-inoculum experiments, 5-day-old rats were intranasally inoculated with 106 to 107 bacteria of a mixture of an S. aureus strain(s) (Newman, PS80, KatA, or a mixture of Newman and KatA) and an S. pneumoniae strain (TIGR4 or SpxB) at a ratio of 1:5 (S. aureus to S. pneumoniae). For each pairing between an S. aureus strain and an S. pneumoniae strain, this experiment was replicated in three different groups of 6 to 12 rats; results from a single replicate are shown (all others are available at www.eclf.net).
For the experiments testing whether S. aureus can invade when S. pneumoniae is established, groups of six 3-day-old rats were inoculated in both nostrils with 106 S. pneumoniae bacteria (TIGR4 or SpxB) or with PBS. All of these rats were then inoculated 48 h later with 106 to 107 S. aureus bacteria (Newman, PS80, KatA, or a mixture of Newman and KatA). For each pairing between an S. aureus strain and an S. pneumoniae strain, this experiment was replicated in two different groups of 6 to 12 rats; results from a single replicate are shown (all others are available on www.eclf.net).
Statistical analysis.
Welch's t test was used to evaluate the statistical significance of H2O2 production by S. pneumoniae for the bacterial density of S. aureus following growth on agar surfaces or during nasal colonization. To ascertain whether catalase-producing S. aureus was being selected during nasal colonization, the selection rate constant (rnk) was calculated. The selection rate is a measure of the relative recoveries of the catalase-producing S. aureus strain (Newman) and the catalase-deficient S. aureus strain (KatA) inoculated into the nasal passages over the 48 h and is given by rnk = [Nn(48)/Nn(0)] – [Nk(48)/Nk(0)], where Nn(0) and Nk(0) are the initial densities in the inoculum of Newman and KatA, respectively, and Nn(48) and Nk(48) are the densities detected at the specific site after 48 h in the rat (22). A selection rate of 0 indicates that there is no selection for catalase production, and a positive rate indicates an advantage for the catalase-producing strain. The P values given for the selection rates were determined using the two-tailed probability (from the t distribution with n – 1 degrees of freedom) of rejecting by chance the null hypothesis that the selection rate constant equals zero, indicating equal fitness for the catalase-producing (Newman) and catalase-deficient (KatA) strains.

RESULTS
Previously it has been shown that in vitro H
2O
2 production by
S. pneumoniae limits the growth of
S. aureus in liquid culture
(
19). To determine whether this occurs in vivo, neonatal rats
were used, because both
S. aureus and
S. pneumoniae readily
colonize the nasal passages of neonatal rats in single-clone
and mixed cultures (with low inoculum densities). Within 48
h after a single species is inoculated alone, both
S. aureus and
S. pneumoniae reach a population of 10
3 CFU/ml in the nasal
wash and epithelium, and this population is maintained for at
least 5 days (data not shown). Despite large individual variation
in bacterial densities with either species, the average bacterial
densities in neonatal rats are similar to the bacterial loads
reported for humans (
20). To determine whether H
2O
2 plays a
role in competition during colonization when both
S. pneumoniae and
S. aureus are introduced in a mixed inoculum, 5-day-old
neonatal rats were challenged with a mixture of
S. pneumoniae and
S. aureus. The three strains of
S. aureus were separately
mixed with either an H
2O
2-producing
S. pneumoniae strain (TIGR4)
or a non-H
2O
2-producing
S. pneumoniae strain (SpxB). If H
2O
2 produced by
S. pneumoniae killed the
S. aureus, one would expect
that
S. aureus would reach a statistically significantly lower
density in the presence of the H
2O
2-producing strain (TIGR4)
than when inoculation was with SpxB. This was not observed (Fig.
1).
Since the amount of H
2O
2 produced is proportional to the number
of bacteria, the maximum amount of H
2O
2 would be present when
the population of the producing strain was at a high density.
Consequently, one would expect that H
2O
2 production would be
most effective in preventing invasion in habitats that are already
colonized by the H
2O
2-producing population. To ascertain whether
this is the case for
S. pneumoniae H
2O
2 production,
S. aureus was inoculated intranasally into neonatal rats with established
populations (inoculated 48 h earlier) of either H
2O
2-producing
(TIGR4) or non-H
2O
2-producing (SpxB)
S. pneumoniae. At 48 h,
the nasal wash and epithelium were sampled and the densities
of both
S. pneumoniae and
S. aureus estimated. The results of
this experiment suggest that
S. aureus is equally able to invade
populations of
S. pneumoniae in the nasal passages of rats whether
the
S. pneumoniae strain is capable of producing H
2O
2 or not
and whether the
S. aureus produces catalase or not (Fig.
2).
One explanation for why
S. aureus is uninfected by
S. pneumoniae-produced
H
2O
2 during cocolonization and is able to invade established
populations of H
2O
2-producing
S. pneumoniae is that wild-type
S. aureus produces a sufficient amount of catalase to neutralize
the H
2O
2. Recent results by Park and colleagues (
14) suggest
that this may be the case. In their experiments with a mouse
cocolonization model,
S. pneumoniae producing H
2O
2 selected
for catalase-producing
S. aureus in mixtures with otherwise
isogenic KatA mutants that do not produce catalase.
To discern whether H2O2 production by S. pneumoniae selects for catalase-producing S. aureus in the neonatal rat model, mixtures of catalase-producing (Newman) and non-catalase-producing (KatA) S. aureus were inoculated either in coinoculation with or invading on an established population of either H2O2-producing (TIGR4) or non-H2O2-producing (SpxB) S. pneumoniae or a PBS buffer control. The selection rate, which compares the relative recoveries of the two strains in the nasal epithelium, measured the competitive performance of the catalase-producing S. aureus strain and the non-catalase-producing S. aureus strain. If the selection rate constant is 0, there is no advantage for the catalase producer, while a value in excess of 0 would mean that catalase production is favored. The results of this experiment for the nasal epithelium are presented in Table 1.
The catalase-producing strain had a marked advantage over the
nonproducer when coinoculated with a non-H
2O
2-producing strain
(SpxB); however, there was no detectable selection for catalase
production without
S. pneumoniae present (PBS control) or with
coinoculation with the H
2O
2-producing strain (TIGR4). The selective
advantage for catalase production was even more pronounced when
the mixture of
S. aureus strains was invading neonatal rats
with established populations of
S. pneumoniae. In this case,
the fitness advantage of the catalase-producing strain was significant
regardless of whether the established
S. pneumoniae strain produced
H
2O
2. Similar results were obtained when fitness was estimated
from densities determined from the nasal wash (results not shown).

DISCUSSION
The hypothesis that hydrogen peroxide-mediated killing of
S. aureus by
S. pneumoniae is responsible for the relative scarcity
of cocolonization of these two species of bacteria is appealing.
It provides an explanation for why the increase in invasive
S. aureus infections could be due to the vaccine-associated
decrease in pneumococcal colonization. This hypothesis is supported
not only by epidemiological studies (
1,
7,
11,
16,
24) but also
by in vitro experiments (
19) that show that H
2O
2 produced by
S. pneumoniae is bactericidal to
S. aureus and limits the density
which
S. aureus reaches in liquid culture. The neonatal rat
nasal colonization results of this study are inconsistent with
this hypothesis. Hydrogen peroxide production provided no advantage
to
S. pneumoniae in competing with
S. aureus either in colonizing
the nasal mucosa of these rats or preventing established populations
of
S. pneumoniae from being colonized by
S. aureus. Although
the results of our experiments indicated that the production
of catalase (which neutralizes H
2O
2) provides a competitive
advantage to
S. aureus in the presence of
S. pneumoniae, that
advantage occurred whether
S. pneumoniae was H
2O
2 producing
or not.
I propose three classes of explanations for why S. pneumoniae-mediated H2O2 killing of S. aureus is effective in vitro but fails to prevent colonization of S. aureus in the nasal passages of neonatal rats: (i) S. pneumoniae does not produce H2O2 in sufficient quantities in vivo, (ii) H2O2 produced in the nasal passages is inactivated either by the host or by other members of the nasal flora, or (iii) the rate of replication of S. aureus more than makes up for killing by S. pneumoniae-produced H2O2. In support of the first explanation is the observation that in broth when S. pneumoniae is at low densities relative to S. aureus, there are insufficient amounts of H2O2 to inhibit the growth of S. aureus (16). The same would be expected on surfaces (plates or nasal epithelium) if the S. aureus and S. pneumoniae colonies are too far apart for S. aureus to come into contact with the zone of inhibition formed by S. pneumoniae (3). This may have been the case in the nasal passages of neonatal rats if S. aureus and S. pneumoniae were not colocalized in the nasal passages or if their densities were too low. It should be noted that in the neonatal rat, at least the recovered density of S. aureus or S. pneumoniae was never greater than 105 CFU/nose. It would be of interest to ascertain whether the densities of S. pneumoniae in the nasal passages of humans are greater than that observed in these rats. In support of the second explanation is the observation that the nasal epithelium produces both catalase and glutathione peroxidase (a scavenger of H2O2) (4). As for the third explanation, I am unaware of estimates of the exponential growth rates of S. aureus in the nasal passage, much less the extent to which that growth rate is reduced by H2O2 killing.
Although the results of these experiments are consistent with earlier observations that catalase production provides a fitness advantage to S. aureus when it is coinoculated with S. pneumoniae in a mouse model (14), they suggest that this advantage is not due to the production of H2O2 by S. pneumoniae. In my experiments, this advantage of catalase-producing S. aureus over otherwise isogenic strains that did not produce this enzyme occurred whether the S. pneumoniae in the nasal epithelia of the rats can produce H2O2 or not. Why, then, would catalase production provide a fitness advantage to S. aureus only when S. pneumoniae is present? Perhaps in this habitat catalase production by S. aureus increases the survival rate in neutrophils by reducing oxidative stress (6, 8), or S. pneumoniae may indirectly select for catalase production in S. aureus, as the presence of both species could synergistically elicit a stronger innate immune response (particularly neutrophil infiltration) as has recently been observed for Haemophilus influenzae and S. pneumoniae (10, 15).
The results of the study can be seen as a cautionary tale, with the moral being that what occurs in a flask may not predict what occurs in a bacterium's natural habitat. They also support the recent epidemiological evidence reported by Regev-Yochay and colleagues (17) that H2O2 is not the major determinant to explain the pattern of cocolonization. Why, then, is S. pneumoniae-S. aureus cocolonization rarer than expected? One can speculate that the scarcity of cocolonization may be due either to different host preferences by these bacterial species or to competitive interactions other than H2O2 allelopathy, perhaps resource or immune-mediated competition (18). In support of the possibility of immune-mediated competition, there was a negative association between S. pneumoniae and S. aureus colonization only in human immunodeficiency virus-negative children and not in human immunodeficiency virus-positive carriers (11). Distinguishing between bacterial interactions and host preferences is especially important for vaccination efforts; reducing the incidence of one species with a vaccine may have the undesired consequence of increasing the incidence of a competing commensal or pathogenic species.

ACKNOWLEDGMENTS
I am particularly grateful to George Liu, Marc Lipsitch, and
Bill Shafer for generously providing strains. I would like to
thank my advisor, Bruce Levin, for his constant support and
his persistent kibitzing. Thanks go to both Bruce and Rebecca
Sanders for critically reading an earlier version of the manuscript
and making many insightful comments and suggestions.
This research was supported by NIH grant AI40662 (to Bruce Levin) and NIH grant T32GM08169 (Emory Medical Scientist Training Program).

FOOTNOTES
* Mailing address: Department of Biology, Emory University, Atlanta, GA 30322. Phone: (404) 727-2956. Fax: (404) 727-2880. E-mail:
emargol{at}emory.edu 
Published ahead of print on 14 November 2008. 

REFERENCES
1 - Bogaert, D., A. van Belkum, M. Sluijter, A. Luijendijk, R. de Groot, H. C. Rmke, H. A. Verbrugh, and P. W. M. Hermans. 2004. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363:1871-1872.[CrossRef][Medline]
2 - Briles, D. E., L. Novak, M. Hotomi, F. W. van Ginkel, and J. King. 2005. Nasal colonization with streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci. Infect. Immun. 73:6945-6951.[Abstract/Free Full Text]
3 - Chao, L., and B. R. Levin. 1981. Structured habitats and the evolution of anticompetitor toxins in bacteria. Proc. Natl. Acad. Sci. USA 78:6324-6328.[Abstract/Free Full Text]
4 - Coursin, D. B., H. P. Cihla, T. D. Oberley, and L. W. Oberley. 1992. Immunolocalization of antioxidant enzymes and isozymes of glutathione stransferase in normal rat lung. Am. J. Physiol. 263:L679-L691.[Medline]
5 - Herz, A. M., T. L. Greenhow, J. Alcantara, J. Hansen, R. P. Baxter, S. B. Black, and H. R. Shinefield. 2006. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr. Infect. Dis. J. 25:293-300.[CrossRef][Medline]
6 - Kanafani, H., and S. E. Martin. 1985. Catalase and superoxide dismutase activities in virulent and nonvirulent Staphylococcus aureus isolates. J. Clin. Microbiol. 21:607-610.[Abstract/Free Full Text]
7 - Madhi, S. A., P. Adrian, L. Kuwanda, C. Cutland, W. C. Albrich, and K. P. Klugman. 2007. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae—and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization—in HIV-infected and HIV-uninfected children. J. Infect. Dis. 196:1662-1666.[CrossRef][Medline]
8 - Mandell, G. L. 1975. Catalase, superoxide dismutase, and virulence of staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal-leukocyte interaction. J. Clin. Investig. 55:561-566.
9 - Margolis, E., and B. R. Levin. 2007. Within-host evolution for the invasiveness of commensal bacteria: an experimental study of bacteremias resulting from Haemophilus influenzae nasal carriage. J. Infect. Dis. 196:1068-1075.[CrossRef][Medline]
10 - Matthias, K. A., A. M. Roche, A. J. Standish, M. Shchepetov, and J. N. Weiser. 2008. Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J. Immunol. 180:6246-6254.[Abstract/Free Full Text]
11 - McNally, L. M., P. M. Jeena, K. Gajee, A. W. Sturm, A. M. Tomkins, H. M. Coovadia, and D. Goldblatt. 2006. Lack of association between the nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus in HIV-1-infected South African children. J. Infect. Dis. 194:385-390.[CrossRef][Medline]
12 - Moxon, E. R., A. L. Smith, D. R. Averill, and D. H. Smith. 1974. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J. Infect. Dis. 129:154-162.[Medline]
13 - Moxon, E. R., and K. A. Vaughn. 1981. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J. Infect. Dis. 143:517-524.[Medline]
14 - Park, B., V. Nizet, and G. Y. Liu. 2008. Role of Staphylococcus aureus catalase in niche competition against Streptococcus pneumoniae. J. Bacteriol. 190:2275-2278.[Abstract/Free Full Text]
15 - Ratner, A. J., E. S. Lysenko, M. N. Paul, and J. N. Weiser. 2005. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc. Natl. Acad. Sci. USA 102:3429-3434.[Abstract/Free Full Text]
16 - Regev-Yochay, G., R. Dagan, M. Raz, Y. Carmeli, B. Shainberg, E. Derazne, G. Rahav, and E. Rubinstein. 2004. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 292:716-720.[Abstract/Free Full Text]
17 - Regev-Yochay, G., R. Malley, E. Rubinstein, M. Raz, R. Dagan, and M. Lipsitch. 2008. In vitro bactericidal activity of Streptococcus pneumoniae and bactericidal susceptibility of Staphylococcus aureus strains isolated from cocolonized versus noncocolonized children. J. Clin. Microbiol. 46:747-749.[Abstract/Free Full Text]
18 - Regev-Yochay, G., K. Trzcinski, C. M. Thompson, M. Lipsitch, and R. Malley. 2007. spxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J. Bacteriol. 189:6532-6539.[Abstract/Free Full Text]
19 - Regev-Yochay, G., K. Trzcinski, C. M. Thompson, R. Malley, and M. Lipsitch. 2006. Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J. Bacteriol. 188:4996-5001.[Abstract/Free Full Text]
20 - Solberg, C. O. 1965. A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimations. Acta Med. Scand. Suppl. 436:1-96.[Medline]
21 - Tettelin, H., K. E. Nelson, I. T. Paulsen, J. A. Eisen, T. D. Read, S. Peterson, J. Heidelberg, R. T. DeBoy, D. H. Haft, R. J. Dodson, A. S. Durkin, M. Gwinn, J. F. Kolonay, W. C. Nelson, J. D. Peterson, L. A. Umayam, O. White, S. L. Salzberg, M. R. Lewis, D. Radune, E. Holtzapple, H. Khouri, A. M. Wolf, T. R. Utterback, C. L. Hansen, L. A. McDonald, T. V. Feldblyum, S. Angiuoli, T. Dickinson, E. K. Hickey, I. E. Holt, B. J. Loftus, F. Yang, H. O. Smith, J. C. Venter, B. A. Dougherty, D. A. Morrison, S. K. Hollingshead, and C. M. Fraser. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498-506.[Abstract/Free Full Text]
22 - Travisano, M., and R. E. Lenski. 1996. Long-term experimental evolution in Escherichia coli. iv. Targets of selection and the specificity of adaptation. Genetics 143:15-26.[Abstract]
23 - Veenhoven, R., D. Bogaert, C. Uiterwaal, C. Brouwer, H. Kiezebrink, J. Bruin, E. Izerman, P. Hermans, R. de Groot, B. Zegers, W. Kuis, G. Rijkers, A. Schilder, and E. Sanders. 2003. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361:2189-2195.[CrossRef][Medline]
24 - Watson, K., K. Carville, J. Bowman, P. Jacoby, T. V. Riley, A. J. Leach, D. Lehmann, and the Kalgoorlie Otitis Media Research Project Team. 2006. Upper respiratory tract bacterial carriage in aboriginal and non-aboriginal children in a semi-arid area of western Australia. Pediatr. Infect. Dis. J. 25:782-790.[CrossRef][Medline]
Journal of Bacteriology, January 2009, p. 571-575, Vol. 191, No. 2
0021-9193/09/$08.00+0 doi:10.1128/JB.00950-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.